Cartridges for immunoassay tests and methods of using the same
US-11879901-B2 · Jan 23, 2024 · US
US9040251B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9040251-B2 |
| Application number | US-201013388671-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 29, 2010 |
| Priority date | Aug 4, 2009 |
| Publication date | May 26, 2015 |
| Grant date | May 26, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention provides a biomolecule modifying substrate comprising biomolecules selectively fixed to given regions thereon. The biomolecule modifying substrate comprises: a substrate at least comprising a first surface and a second surface; a first linker molecule comprising a hydrocarbon chain and a functional group capable of selectively binding to the first surface at one end of the hydrocarbon chain, which is bound to the first surface via such functional group; a second linker molecule comprising a reactive group capable of binding to the hydrocarbon chain of the first linker molecule, which is bound to the first linker molecule via a bond between the reactive group and the hydrocarbon chain; and a biomolecule bound thereto via the second linker molecule.
Opening claim text (preview).
The invention claimed is: 1. A biomolecule modifying substrate comprising: a substrate; a first surface on the substrate, the first surface comprising a metal oxide; a second surface on the substrate, the second surface comprising a noble metal; a first linker molecule comprising a hydrocarbon chain and a functional group at one end or in a side chain of the hydrocarbon chain, the functional group capable of selectively binding to the first surface, the first linker molecule bound to the first surface via the functional group; a second linker molecule comprising biotin and a reactive group, the reactive group capable of binding to the hydrocarbon chain of the first linker molecule, the second linker molecule bound to the first linker molecule via a bond between the reactive group and the hydrocarbon chain; a biomolecule comprising an introduced biotin; and an avidin, wherein the biotin contained in the second linker molecule is bound to the biotin introduced into the biomolecule via the avidin, and wherein the functional group of the first linker molecule capable of selectively binding to the first surface is a phosphate group. 2. The biomolecule modifying substrate according to claim 1 , wherein the first surface is a metal having a natural oxide film. 3. The biomolecule modifying substrate according to claim 1 , wherein the hydrocarbon chain of the first linker molecule comprises an alkyl group and is represented by the formula selected from the group consisting of C m H 2m-1 PO 3 H 2 , C m H 2m-1 OPO 3 H 2 , wherein m is an integer between 2 and 20. 4. The biomolecule modifying substrate according to claim 1 , wherein the hydrocarbon chain of the first linker molecule is a polymer chain comprising a phosphate group in the side chain of a compound represented by formula 3: wherein n is an integer of 1 or larger. 5. The biomolecule modifying substrate according to claim 1 , wherein the reactive group in the second linker molecule is a latent reactive group capable of binding to the hydrocarbon chain and the latent reactive group is at least 1 type of photoreactive compound selected from the group consisting of an anthrathione group, an anthraquinone group, a benzophenone group, an azide group, and a derivative of any thereof. 6. The biomolecule modifying substrate according to claim 1 , wherein the second linker molecule further comprises a reactive group capable of selectively binding to the biomolecule or a reactive group bound to the biomolecule. 7. The biomolecule modifying substrate according to claim 1 , wherein the first linker molecule lacks a functional group inhibiting binding between the second linker molecule and the hydrocarbon chain of the first linker molecule, and wherein the first linker molecule lacks a functional group capable of binding to the second surface. 8. The biomolecule modifying substrate according to claim 1 , wherein the hydrocarbon chain of the first linker molecule comprises an alkyl group, and wherein functional group of the second linker molecule is bonded to the alkyl group of the first linker molecule.
with ligand attached to the carrier via a chemical coupling agent (coatings G01N33/54393) · CPC title
Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding · CPC title
with an insoluble carrier for immobilising immunochemicals · CPC title
binding through the biotin-streptavidin system or similar · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.